chr22-46308717-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016426.7(GTSE1):c.536G>A(p.Gly179Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016426.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GTSE1 | NM_016426.7 | c.536G>A | p.Gly179Asp | missense_variant | 4/12 | ENST00000454366.2 | |
GTSE1 | XM_047441391.1 | c.536G>A | p.Gly179Asp | missense_variant | 3/11 | ||
GTSE1 | XM_047441392.1 | c.536G>A | p.Gly179Asp | missense_variant | 4/10 | ||
GTSE1 | XR_007067974.1 | n.619G>A | non_coding_transcript_exon_variant | 4/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GTSE1 | ENST00000454366.2 | c.536G>A | p.Gly179Asp | missense_variant | 4/12 | 1 | NM_016426.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152268Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000724 AC: 18AN: 248454Hom.: 0 AF XY: 0.0000519 AC XY: 7AN XY: 134930
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461274Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 726904
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152386Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74514
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.536G>A (p.G179D) alteration is located in exon 4 (coding exon 3) of the GTSE1 gene. This alteration results from a G to A substitution at nucleotide position 536, causing the glycine (G) at amino acid position 179 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at